English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

This article considers the semantics employed by various actors in the negotiation and contestation of processes associated with the transnational ‘harmonisation’ of intellectual property law, particularly as these processes impact on access to medicines for HIV/AIDS treatment. I draw on fieldwork conducted with several international organisations concerned with intellectual property in Geneva, Switzerland, to consider the ways in which a diverse set of actors discursively re-signify the practices of pharmaceutical companies that are perceived to limit access to medicines. While this semantics engages with dominant intellectual property concepts, I argue that it simultaneously presages the construction of alternative paradigms. Thus practices and concepts that may initially appear to embrace, or participate in, neoliberal processes, on closer inspection can also turn out to be sites of problematisation.

HIV/AIDS, ‘TRIPS plus’ and ‘Knowledge Ecology:’ Unpacking the Semantics of Transnational Intellectual Property ‘Harmonisation’